ArticleScientific reports2022

Exploration of serum biomarkers in dogs with malignant melanoma receiving anti-PD-L1 therapy and potential of COX-2 inhibition for combination therapy.

Naoya Maekawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.